Advertisement
Personnel News
Subscribe to Personnel News

The Lead

Allergan Reports Second Quarter 2014 Operating Results; Announces Layoffs

July 21, 2014 8:45 am | News | Comments

Allergan, Inc. announced operating results for the quarter ended June 30, 2014 and announced a restructuring that will eliminate 1500 jobs.                   

Aptuit Names Executive VP, Business Development & Marketing; Enhances Sterile Drug Product Capabilities

July 16, 2014 11:33 am | News | Comments

Aptuit LLC has appointed Paul D. Overton, Ph.D., as Executive Vice President, Business...

Bayer Names U.S. Head of Litigation

July 15, 2014 11:28 am | News | Comments

Bayer today announced the appointment of Malini Moorthy as Head of the Litigation Department in...

Repligen Hires Chief Financial Officer

July 15, 2014 8:34 am | News | Comments

Repligen Corporation today announced that Jon K. Snodgres has been named its Chief Financial...

View Sample

FREE Email Newsletter

Merck KGaA’s Biopharmaceutical Division Appoints New Global Head of R&D

July 14, 2014 9:13 am | News | Comments

Merck KGaA’s biopharmaceutical division today announced the appointment of Luciano Rossetti, M.D., as Executive Vice President and Global Head of Research & Development as of July 21, 2014.          

China Indicts US, British Nationals Involved In GSK Investigation

July 13, 2014 11:26 pm | by The Associated Press | News | Comments

Chinese authorities formally indicted two corporate investigators, an American and Briton, for allegedly illegally obtaining and selling private information, state media reported Monday. Prosecutors in Shanghai filed charges against British investigator Peter Humphrey and his wife Yingzeng Yu, a U.S. citizen, at the city's No. 1 Intermediate People's Court, the official Xinhua News Agency said.

ScinoPharm President and CEO to Retire

July 11, 2014 8:04 am | News | Comments

ScinoPharm announced that after 17 years of dedicated service, its co-founder and President & CEO Dr. Jo Shen is retiring at the end of July 2014 and will be succeeded by Dr. Yung-Fa (Fred) Chen, currently Sr. Vice President of R&D and Chief Technology Officer, effective August 1, 2014.

Advertisement

Vertex Announces Retirement of Peter Mueller, Ph.D.

July 10, 2014 8:08 am | News | Comments

Vertex Pharmaceuticals Incorporated today announced that Peter Mueller, Ph.D., Executive Vice President of Global Research and Development and Chief Scientific Officer, will retire after more than 10 years with the company.      

Eisai Increases BELVIQ Sales Force by 50%

July 10, 2014 8:05 am | News | Comments

Arena Pharmaceuticals, reported that Eisai Inc. has completed its planned increase of more than 200 new contract sales representatives in its Metabolic Business Unit, increasing the sales force for BELVIQ by 50% to approximately 600.  

Ortho-Clinical Diagnostics Announces Executive Leadership Additions as It Becomes an Independent, Stand-Alone Company

July 8, 2014 8:58 am | News | Comments

Ortho-Clinical Diagnostics, Inc. unveiled its newly expanded executive leadership team following the acquisition of the company by The Carlyle Group from Johnson & Johnson.             

AAIPharma Services and Cambridge Major Laboratories Name New CEO

July 8, 2014 8:54 am | News | Comments

AAIPharma Services Corp., a global provider of pharmaceutical analytical testing, product development and manufacturing services, and Cambridge Major Laboratories, Inc., a provider pharmaceutical API development and manufacturingservices, announced the appointment of Stephan Kutzer, Ph.D. as Chief Executive Officer (CEO), effective August 1, 2014.

Actavis Closes $28B Forest Deal, Names New CEO

July 1, 2014 1:26 pm | by The Associated Press | News | Comments

Actavis has completed its $28 billion acquisition of fellow drugmaker Forest Laboratories, and the leader of the acquired company is now the CEO of Actavis.                

Advertisement

Alexza Promotes Edwin S. Kamemoto, Ph.D. to Senior Vice President, Regulatory Affairs

June 30, 2014 4:19 pm | News | Comments

Alexza Pharmaceuticals has announced the promotion of Edwin S. Kamemoto, Ph.D., to the newly created position of Senior Vice President, Regulatory Affairs.  Dr. Kamemoto will have primary responsibility for leading and directing all regulatory affairs and global pharmacovigilence activities.

Former Proctor & Gamble Exec to Head VA

June 30, 2014 7:54 am | by JULIE PACE, AP White House Correspondent | News | Comments

Seeking to turn around a troubled agency, President Barack Obama will nominate former Procter & Gamble executive Robert McDonald to lead a Veterans Affairs department gripped by reports of treatment delays and cover-ups.     

Tris Pharma Adds Chief Medical Officer and VP of Regulatory Affairs

June 26, 2014 8:06 am | News | Comments

Tris Pharma, a specialty pharmaceutical company focused on developing innovative technology-based products announced two key additions to its' executive team:  Sally A. Berry, MD, PhD  will join as Chief Medical Officer and Norma Cappetti will join as Vice President of Regulatory Affairs.

InVivo Therapeutics Realigns R&D Strategy – Cuts Staff

June 24, 2014 8:27 am | News | Comments

As a result of an in-depth review of the company’s research & development portfolio, InVivo Therapeutics has announced that the company is realigning resources behind its novel Neuro-Spinal Scaffold and the Neuro-Spinal Scaffold Plus Stem Cells program for spinal cord injury (SCI).

Eisai Appoints New Vice President and Chief Financial Officer

June 23, 2014 8:58 am | News | Comments

Eisai Inc., the U.S. pharmaceutical subsidiary of Eisai Co., Ltd., today announced the immediate appointment of Barry Lederman to the position of Vice President and Chief Financial Officer (CFO). In this role, Mr.Lederman will have full oversight and responsibility for leading Eisai's financial operations in the Americas Region.

Advertisement

Actavis and Forest Labs Appoint Exec to Lead Actavis Global Brands Research and Development

June 23, 2014 8:54 am | News | Comments

Actavis and Forest Labs today announced that C. David Nicholson, PhD will be appointed Senior Vice President, Actavis Global Brands R&D following the close of Actavis' planned acquisition of Forest.  In this role, Dr. Nicholson will lead the global teams focused on developing Actavis' significantly expanded branded R&D portfolio, as well as defining long-term product development strategies and collaborations.

Noven Appoints Krista Roberts as Vice President of Operations

June 23, 2014 8:04 am | News | Comments

Noven Pharmaceuticals announced the appointment of Krista Roberts as the company’s new Vice President of Operations. In this role, Roberts will be responsible for all Noven manufacturing and related operations.      

BASi Names Names New CFO and VP Bioanalytical Operations

June 12, 2014 8:27 am | News | Comments

Bioanalytical Systems, Inc. (BASi) today announced the appointment of Jeffrey Potrzebowski as Chief Financial Officer and James S. Bourdage, Ph.D., as Vice President Bioanalytical Operations.          

Bayer CEO to Leave Company at End of 2016

June 4, 2014 8:16 am | News | Comments

In line with his own wishes, the contract of Dr. Marijn Dekkers will be extended by just two years on expiration of the initial five-year period. Dekkers cited family reasons for extending his contract only until the end of 2016.    

Teva Announces New Organizational Structure and Senior Leadership Changes

June 2, 2014 3:47 pm | News | Comments

Teva Pharmaceutical Industries has announced a new organizational structure and related executive positions, designed to achieve seamless global integration, focus and effectiveness across the company. The changes will become effective July 1st.

Pfizer Names Chief Scientific Officer, Cardiovascular and Metabolic Disease Research

May 29, 2014 11:33 am | News | Comments

Pfizer announced that Morris J. Birnbaum, M.D., Ph.D., has joined the company as Chief Scientific Officer for Cardiovascular and Metabolic Disease Research. He will report directly to Rod MacKenzie, Ph.D., Group Senior Vice President and Head of PharmaTherapeutics Research & Development, and will be based in a key Pfizer R&D hub in Cambridge, MA.

Median CEO Pay Crosses $10M in 2013

May 28, 2014 8:59 am | by KEN SWEET, AP Business Writer | News | Comments

Last year was the fourth straight that CEO compensation rose following a decline during the Great Recession. The median CEO pay package climbed more than 50 percent over that stretch. A chief executive now makes about 257 times the average worker's salary.

Ben Venue Labs to Sell Assets of Bedford Labs to Hikma Pharmaceuticals

May 28, 2014 8:47 am | News | Comments

Hikma will be acquiring Bedford Laboratories' assets, including a large product portfolio, intellectual property rights, contracts for products marketed under license, raw material inventories, a strong research and development and business development pipeline, and a number of employees across key business functions.

PAREXEL Names Chief Scientific Officer

May 27, 2014 9:07 am | News | Comments

PAREXEL International, a global biopharmaceutical services organization, today named Dr. Sy Pretorius its Chief Scientific Officer. Dr. Pretorius currently serves as the company's Corporate Vice President and Worldwide Head of Early Phase, and will continue in that capacity in addition to assuming his expanded responsibilities.

Top 10 Highest-Paid CEOs

May 27, 2014 8:07 am | News | Comments

Here are the 10 highest-paid CEOs of 2013, as calculated by The Associated Press and Equilar, an executive pay research firm.                      

Celgene Makes Changes to Leadership Team

May 22, 2014 8:07 am | News | Comments

Celgene Corporation today announced several organizational changes that will go into effect on August 1, 2014.                       

Purdue Pharma Names New Senior Vice President and Chief Commercial Officer

May 22, 2014 8:03 am | News | Comments

Purdue Pharma today announced that Saeed Motahari has joined the company as Senior Vice President and Chief Commercial Officer.                     

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading